Dexcom’s Jake Leach And Adrian Gut Discuss Strategy For CGM Growth, Reimbursement, AI Integration And Policy Challenges

Dexcom Executives Tackle Key Issues Shaping The Future Of CGM Technology Worldwide

 
• By Shubham Singh

In an interview with Medtech Insight, Dexcom’s COO Jake Leach and Adrian Gut, senior director international access, discuss the company’s global expansion, the role of AI in diabetes management, the challenges of securing reimbursement, and how regulators are influencing the future of CGM technology.

In this in-depth conversation, they discuss the challenges of expanding Dexcom’s global footprint, the company’s reimbursement strategy, and the evolving role of regulators in fostering innovation.

More from Interviews

More from Medtech Insight